1Jacobi J,Fraser GL,Coursin DB,et al.Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.Crit Care Med,2002,30:119-141.
2Ostermann ME,Keenan SP,Seiferling RA,et al.Sedation in the intensive care unit:a systematic review.JAMA,2000,283:1451-1459.
3Hayaahi Y,Maze M.Alpha2 adrenoceptor agonists and anaesthesia.Br J Anaesth,1993,71:108-118.
4Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists,their pharmacology and therapeutic role.Anaesthesia,1999,54:146-165.
6Maze M,Scarfini C,Cavaliere F.New agents for sedation in the intensive care unit.Crit Care Clin,2001,17:881-897.
7Venn RM,Bryant A,Hall GM,et al.Effects of dexmedetomidine on adrenocortical function,and the cardiovascular,endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit.Br J Anaesth,2001,86:650-656.
8Herr DL,Sum-Ping ST,England M.ICU sedation after coronary artery bypass graft surgery:dexmedetomidine-based versus propofol-based sedation regimens.J Cardiothorac Vasc Anesth,2003,17:576-584.
9Venn RM,Grounds RM.Comparison between dexmedetomidine and propofol for sedation in the intensive care unit:patient and clinician perceptions.Br J Anaesth,2001,87:684-690.
10Martin E,Ramsay G,Mantz J,et al.The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit.J Intensive Care Med,2003,18:29-41.
